vimarsana.com
Home
Live Updates
Prostate cancer drug shortage may resolve in late 2023, company says : comparemela.com
Prostate cancer drug shortage may resolve in late 2023, company says
Pluvicto, a prostate cancer drug manufactured by Novartis, has been in short supply for several months, but that may soon resolve the company says.
Related Keywords
New Jersey ,
United States ,
Italy ,
,
Novartis ,
Street Journal ,
Pluvicto ,
Prostate Cancer ,
Drug Manufacturer ,
Supply Chain ,
Drug Supply ,
Pharma Supply ,
Pharmaceutical Supply Chain ,
Ending ,
Abc ,
comparemela.com © 2020. All Rights Reserved.